Dr. Jay S. Skyler Recognized as a Fellow of the Royal College of Physicians of London
After a medical career spanning more than five decades, endocrinologist Jay S. Skyler, M.D., professor of medicine and deputy director for clinical research and academic programs at the University of Miami Miller School of Medicine Diabetes Research Institute, has been recognized as a Fellow of the Royal College of Physicians of London (RCP).
The honor is due in part to the relationship between the American College of Physicians (ACP), in which Dr. Skyler was named a Master in 2005, and the RCP. The ACP nominates a select few members each year who are Masters to be considered by the RCP for fellowship.
“It has been a rigorous process, and I do feel honored,” Dr. Skyler said. “It’s very special to become a Fellow of the RCP and to be the only one in the Department of Medicine with that distinction.”
Dr. Skyler’s work leading research efforts into type 1 diabetes has been extensive. His research was funded by the National Institutes of Health from 1979–2015 and then again in 2017. For 22 years, he led the type 1 diabetes clinical trials network for NIDDK, aimed at halting the type 1 diabetes disease process. His work also includes clinical aspects of diabetes and improving the care of type 1 diabetes through meticulous glycemic control, psychosocial and behavioral support, focusing on immune intervention. He has earned numerous awards and has authored more than 525 publications and 21 books while also serving on multiple editorial boards. He was the founding scientific editor of Diabetes Care, the clinical research journal of the American Diabetes Association.
Dr. Skyler also served in many notable leadership positions, such as Board of Regents member of the ACP, past president of the American Diabetes Association, and vice president of the International Diabetes Association.
As a Fellow, Dr. Skyler wants to first get better acquainted with the RCP. The RCP offers various Zoom conferences and networking opportunities with its members in more than 80 countries.
His overall goal remains the same as it was when he was a medical student conducting research.
“What comes next is the same mission I’ve always had — to erase type 1 diabetes,” Dr. Skyler said. “That’s what I’ve been trying to do my entire life.”
Content Type article